FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast CancerLaleh Amiri‐Kordestani, Patricia Cortazar, Qiang Xu et al.|Clinical Cancer Research|2014Cited by 350